Selected protein kinase inhibitors for the treatment of neurological disorders
US5461146A · kind A · utility
37Cited by
6References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 22, 1993 |
| Grant date | Oct 24, 1995 |
| Priority date | — |
| Expiry date | Jul 22, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features novel derivatives of K-252a, as well as novel bis-N-substituted derivatives of staurosporine. Also, a method for treating diseased neuronal cells involving the administration of either the novel staurosporine derivatives or specified functional derivatives of K-252a.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.